VEGFA and endometriosis: In mouse models, iron oxide-based magnetic nanoparticles encapsulated in PEG-PCL-based nanocarriers successfully target endometriosis tissue by binding vascular endothelial growth factor (VEGF) receptors and increasing T2-weighted signaling via MRI [72].